findmyKOL
Clinical trialNCT03792516CompletedPhase 1Interventional

Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment15HPV-Related Vulvar Intraepithelial NeoplasiaPreinvasive Vulvar DiseaseVulva Intraepithelial NeoplasiaVulvar DiseasesVulvar Dysplasia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase I, proof-of-concept treatment study to evaluate the safety, tolerability and feasibility of topical artesunate ointment to treat high grade vulvar intraepithelial neoplasia (HSIL VIN2/3).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Johns Hopkins Outpatient Center

    Baltimore, Maryland, United States

  • Cleveland Clinic Fairview Hospital

    Cleveland, Ohio, United States

  • Cleveland Clinic Foundation - Main Campus

    Cleveland, Ohio, United States

  • Cleveland Clinic - Hillcrest Hospital

    Mayfield Heights, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Artesunate ointment 40%
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Apr 2019
Primary completion
31 Aug 2022
Completion
3 Dec 2024
Last update posted
4 Dec 2024
Registered enrollment
15
Registry id
NCT03792516
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.